Senores Pharmaceuticals Ltd
NSE: SENORES | BSE: 544319
₹1,112.60
₹18.10
(1.65%)
As on 10-Jun-2026IST
Market cap
₹5,104 Cr
Revenue (TTM)
₹650 Cr
P/E Ratio
44.2
P/B Ratio
5.5
Div. Yield
0 %
Quality Score
1/10
Growth Score
3/10
Valuation Score
4/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹115 Cr
-
ROE
11.8 %
-
ROCE
11.9 %
-
Industry P/E
46.12
-
EV/EBITDA
24.5
-
Debt to Equity
0.2
-
Book Value
₹202.7
-
EPS
₹25.1
-
Face value
10
-
Shares outstanding
46,053,588
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Senores Pharmaceuticals
| 35.3 | 15.2 | 50.1 | 107.9 | -- | -- | -- |
|
BSE Healthcare
| 8.2 | 1.0 | 8.3 | 8.0 | 24.8 | 13.5 | 12.1 |
|
Company
|
2025
|
|---|---|
|
Senores Pharmaceuticals
| 43.9 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Senores Pharmaceuticals
|
1,112.6 | 5,103.7 | 649.5 | 121.6 | 23.7 | 13.2 | 44.2 | 5.5 |
| 1,031.4 | 12,756.9 | 2,551.8 | 564.5 | 28.3 | 18.4 | 22.6 | 3.8 | |
| 469.8 | 8,153.7 | 947.3 | 247.8 | 28.5 | 18.9 | 32.9 | 6.0 | |
| 1,330.7 | 13,785.3 | 1,054.9 | 256.3 | 27.8 | 13.7 | 52.8 | 6.8 | |
| 1,731.2 | 32,856.6 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.5 | 6.6 | |
| 384.1 | 4,240.9 | 165.8 | 46.7 | 37.8 | 16.9 | 90.8 | 14.7 | |
| 16,946.0 | 21,765.5 | 2,023.0 | 364.0 | 23.9 | 20.8 | 59.8 | 11.6 | |
| 851.0 | 4,309.1 | 811.3 | 21.0 | 0.7 | 2.1 | 209.7 | 3.3 | |
| 731.4 | 8,262.2 | 502.0 | 138.7 | -- | 32.8 | 47.8 | 9.4 | |
| 268.8 | 7,040.0 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 11.9 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Senores Pharmaceuticals IPO analysis
5 min read•By Satyajit Sen
About Senores Pharmaceuticals
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as... analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics, as well as management and consultancy services. The company was incorporated in 2017 and is based in Ahmedabad, India. Read more
-
Incorporated
2017
-
Chairman
Sanjay Shaileshbhai Majmudar
-
Managing Director
Swapnil Jatinbhai Shah
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Senores Pharmaceuticals Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Senores Pharmaceuticals
What is the current share price of Senores Pharmaceuticals Ltd Today?
The share price of Senores Pharmaceuticals Ltd is ₹1,112.60 (NSE) and ₹1,111.95 (BSE) as of 10-Jun-2026 IST. Senores Pharmaceuticals Ltd has given a return of 107.94% in the last 1 years.
What is the current PB & PE ratio of Senores Pharmaceuticals Ltd?
The P/E ratio of Senores Pharmaceuticals Ltd is 44.24 times as on 10-Jun-2026, a 4 discount to its peers’ median range of 46.12 times.
The P/B ratio of Senores Pharmaceuticals Ltd is 5.47 times as on 10-Jun-2026, a 62 premium to its peers’ median range of 3.38 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
45.04
|
3.35
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
45.04
|
3.35
|
What is the 52 Week High and Low of Senores Pharmaceuticals Ltd?
The 52-week high and low of Senores Pharmaceuticals Ltd are Rs 1,194.40 and Rs 513.00 as of 10-Jun-2026.
What is the market cap of Senores Pharmaceuticals Ltd?
Senores Pharmaceuticals Ltd has a market capitalisation of ₹ 5,104 Cr as on 10-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Senores Pharmaceuticals Ltd?
Before investing in Senores Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.